Internal Medicine, Hematology · Atlanta, GA
NPI
1366550931
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1365 Clifton Rd NE
Atlanta, GA, 30322
Phone (404) 778-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
175 services
Medicare patients, 2024
51
Average age 67
Drug cost, 2024
$2.8M
445 prescriptions
Company payments, 2025
$37K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edmund K Waller was code 99233 (hospital e&m - subsequent), 50 times for 16 patients. In total Edmund K Waller billed 175 services in 20 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 50 | 16 | $95.68 | $4,784 |
| 99214 Office E&M - Established | Office | 29 | 18 | $73.70 | $2,137 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 11 | $63.59 | $1,717 |
| 99215 Office E&M - Established | Office | 25 | 13 | $105.13 | $2,628 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 18 | 11 | $12.76 | $230 |
By year: 2022 $11K for 158 services; 2023 $7,047 for 88 services; 2024 $14K for 175 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edmund K Waller prescribed most often to Medicare patients was Rezurock (Belumosudil Mesylate), with 80 prescriptions and refills. In total Edmund K Waller wrote 445 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rezurock Belumosudil Mesylate | 80 | 80 | 11 | $1.6M |
| Acyclovir Generic | 46 | 85 | Under 11 | $563 |
| Prevymis Letermovir | 33 | 36 | Under 11 | $240K |
| Valacyclovir Valacyclovir Hcl | 29 | 58 | Under 11 | $1,130 |
| Brukinsa Zanubrutinib | 24 | 24 | Under 11 | $362K |
| Jakafi Ruxolitinib Phosphate | 17 | 17 | Under 11 | $235K |
| Fluconazole Generic | 12 | 12 | Under 11 | $336 |
| Tacrolimus Generic | 12 | 19 | Under 11 | $675 |
| Sirolimus Generic | 11 | 13 | Under 11 | $2,603 |
Brand drugs: - claims; generic drugs: 238 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edmund K Waller $37K ($37K in general payments such as food, travel and fees) from 12 companies. The largest payer was Genzyme Corporation with $29K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.